MA S1304 | 2019-2020 | 191st General Court

Note: Legislation replaced by S1301

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 22 2019 - 25% progression, died in chamber
Action: 2020-06-04 - Accompanied S1301
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation to restore integrity in the marketing of pharmaceutical products and medical devices. Public Health.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To restore integrity in the marketing of pharmaceutical products and medical devices

Sponsors


History

DateChamberAction
2020-06-04SenateAccompanied S1301
2019-08-28JointHearing scheduled for 09/10/2019 from 01:00 PM-05:00 PM in B-1
2019-01-22HouseHouse concurred
2019-01-22SenateReferred to the Joint Committee on Public Health

Same As/Similar To

S224 (Similar To) 2020-03-12 - Accompanied a new draft, see H4559
S232 (Similar To) 2020-04-06 - Bill reported favorably by committee and referred to the committee on Senate Ways and Means
S1809 (Similar To) 2019-12-04 - Bill reported favorably by committee and referred to the committee on Senate Ways and Means
H2951 (Similar To) 2020-02-26 - Bill reported favorably by committee and referred to the committee on House Ways and Means
S1301 (Replaced by) 2020-06-04 - Bill reported favorably by committee and referred to the committee on Senate Ways and Means

Massachusetts State Sources


Bill Comments

feedback